Literature DB >> 23815597

Innate type 2 immunity is associated with eosinophilic pleural effusion in primary spontaneous pneumothorax.

Bo-In Kwon1, Seokchan Hong, Kihyuk Shin, Eun-Hye Choi, Jung-Joo Hwang, Seung-Hyo Lee.   

Abstract

RATIONALE: Eosinophilic pleural effusion (EPE) is characterized by greater than 10% eosinophilia and is frequently associated with air and/or blood in the pleural cavity. Primary spontaneous pneumothorax (PSP), defined as the spontaneous presence of air in the pleural space, is one of the most common causes of EPE. Recent studies have shown that type 2 immune responses play important roles in eosinophilic airway inflammation resulting in pleural pathology.
OBJECTIVES: To determine the predominant immune responses associated with PSP in humans, and to examine whether IL-33, thymic stromal lymphopoietin (TSLP), or type 2 innate lymphoid cell (ILC2)-mediated immune responses are associated factors.
METHODS: Eosinophil-associated cytokines were measured in the pleural fluid of patients with PSP and control subjects. Th2 cell and ILC2 responses in the pleural cavity and peripheral blood were also evaluated by in vitro restimulation and intracellular cytokine staining of T cells and ILC2s in patients with PSP (n = 62) and control subjects (n = 33). IL-33-mediated IL-5 production by ILC2s was also evaluated.
MEASUREMENTS AND MAIN RESULTS: Significantly higher concentrations of IL-5 and eotaxin-3 were detected in the pleural fluid of patients with PSP, in addition to significantly higher concentrations of IL-33 and TSLP. Although IL-5 production was induced by IL-33 treatment of ILC2s, other Th2 cell-mediated immune responses were not detected.
CONCLUSIONS: Our results indicate that innate immune responses characterized by the production of IL-33, TSLP, and IL-5 are associated with the development of EPE in PSP by an ILC2-dependent and Th2-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23815597     DOI: 10.1164/rccm.201302-0295OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  16 in total

Review 1.  At the bedside: the emergence of group 2 innate lymphoid cells in human disease.

Authors:  R Stokes Peebles
Journal:  J Leukoc Biol       Date:  2014-12-16       Impact factor: 4.962

Review 2.  Group 2 innate lymphoid cells in health and disease.

Authors:  Brian S Kim; David Artis
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-08       Impact factor: 10.005

Review 3.  Approaches to Evaluate Lung Inflammation in Translational Research.

Authors:  David K Meyerholz; Jessica C Sieren; Amanda P Beck; Heather A Flaherty
Journal:  Vet Pathol       Date:  2017-08-16       Impact factor: 2.221

Review 4.  Innate lymphoid cells and allergic disease.

Authors:  Matthew T Stier; R Stokes Peebles
Journal:  Ann Allergy Asthma Immunol       Date:  2017-12       Impact factor: 6.347

Review 5.  Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation.

Authors:  Rohit Divekar; Hirohito Kita
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-02

Review 6.  Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease.

Authors:  Maya R Karta; David H Broide; Taylor A Doherty
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

Review 7.  Group 2 innate lymphoid cells in the lung.

Authors:  Li Yin Drake; Hirohito Kita
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

8.  Enhanced innate type 2 immune response in peripheral blood from patients with asthma.

Authors:  Kathleen R Bartemes; Gail M Kephart; Stephanie J Fox; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2014-09       Impact factor: 10.793

9.  Pleural Effusion IL-33/sST2 Levels and Effects of Low and High IL-33/sST2 Levels on Human Mesothelial Cell Adhesion and Migration.

Authors:  Ourania S Kotsiou; Rajesh M Jagirdar; Eleftherios D Papazoglou; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Inflammation       Date:  2019-12       Impact factor: 4.657

Review 10.  Friend or foe of innate lymphoid cells in inflammation-associated cardiovascular disease.

Authors:  Xiangmei Gong; Lin Xia; Zhaoliang Su
Journal:  Immunology       Date:  2020-10-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.